• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Fibroleukin (FGL2)

ACP09264

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09264 Target NameFGL2
Target SynonymsFGL2; FGL2_HUMAN; fibrinogen like 2; Fibrinogen like protein 2; Fibrinogen-like protein 2; Fibroleukin; pT49; T49FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range24-439
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14314
Background Information
  • Uniprot Id

    Q14314

  • Target Species

    Human

  • Target Name

    FGL2

  • Target Full Name

    Fibroleukin

  • Target Function

    May play a role in physiologic lymphocyte functions at mucosal sites.

  • Target Subcellular Location

    Secreted.

  • Target Tissue Specificity

    Constitutively expressed in cytotoxic T-cells.

  • Target Research Area

    Immunology

  • Target Synonyms

    FGL2; FGL2_HUMAN; fibrinogen like 2; Fibrinogen like protein 2; Fibrinogen-like protein 2; Fibroleukin; pT49; T49

  • Target Background

    The protein encoded by this gene is a secreted protein that is similar to the beta- and gamma-chains of fibrinogen. The carboxyl-terminus of the encoded protein consists of the fibrinogen-related domains (FRED). The encoded protein forms a tetrameric complex which is stabilized by interchain disulfide bonds. This protein may play a role in physiologic functions at mucosal sites.

Inquire Recombinant Human Fibroleukin (FGL2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification